| Tag | Content |
|---|
EnhancerAtlas ID | HS134-31434 |
Organism | Homo sapiens |
Tissue/cell | Mesendoderm |
Coordinate | chr2:137003560-137004270 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| RREB1 | MA0073.1 | chr2:137003791-137003811 | TGGTGGGGGGTGGGGGAGGG | - | 6.27 | | ZNF263 | MA0528.1 | chr2:137003802-137003823 | GGGGGAGGGAGAGGCAGAGGG | + | 7.41 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_09631 | chr2:137003084-137005745 | CD14 | | SE_10274 | chr2:137003280-137004192 | CD19_Primary | | SE_35084 | chr2:137002524-137006118 | HeLa | | SE_61425 | chr2:136945577-137039880 | Toledo | | SE_62403 | chr2:136962507-137014815 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I136245 | chr2 | 137003172 | 137004510 |
|
Enhancer Sequence | GATCAAGCAC CTGCTGGGTT AGGGGGTTAC AAAAAGTTGT GGGACAGGGC TGTTGGTTTG 60
GCCTCTCATC TTCGTGGGAG GATCCTTACC CCTGGCCAAG GCAAGGGGCT CACACAGCCT 120
CTCAGGAGGA CTGTGGCCAA AGGACAAAAC CAAACTCCTC CCCCGATATC AGGCTGTGAG 180
CCAAAGGAGC CTTGAACTGT GGCAATGGCA ACTACCACCC AGAAGCAGTG CTGGTGGGGG 240
GTGGGGGAGG GAGAGGCAGA GGGAAGCCGG TGGTGGTCTG ACAGGCAGCG GGGCAGACAG 300
GGGTTATTGA AGGGCATGGC CTGCCTCCAC GATTACTCAA AAGCAAGCTG CACTTCTTAC 360
TGGCCCTTTA AGAACGGCGC CTACGTGATG AAATGCCAGG GCTGAGTGGA AGCCCAGAGA 420
GTGTGACCAG AAGCCACTCC CTCTGTGCTG AGAGTCACGC AATCTATGGT CCATGCCCGC 480
GAGTGACTGG GAGCTTGTTT GTGTGGGGGG CTGTTCCCGC AGCTGGAAGC CCCAGGTAAT 540
CCCAACCCCC TGCAACTCAC AGATGATACT AAACTAAACA GCCCTGGCTG CCTCTGCCTC 600
GGACCCCATG TTCTCTTTCC CTCTTCCTAG GTGTCAAAGG GCTTAGACTA GACGCGTGTT 660
TCCCCAAATG CGCTTTTGGG TACCACTGGC AAAACACAAA CCAAATTTAG 710
|
